Dergiler / Pediatric Practice and Research / 2019 / Cilt: 7 - Sayı: 2

Screening for G6PD Enzyme Deficiency Among Children aged Five Years and Below in Diyala Province / Iraq.

Sayfa
9–14
Yayın Tarihi
2019-08-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The prevalence of G6PD enzyme deficiency is low, so screening for the enzyme deficiency is not warranted at least in Diyala province.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: G6PD deficiency is the most common gene mutation in the world and the numerous mutations have been classified by the WHO.
📊
Temel Bulgular & Veri:Objective: is to estimate the prevalence of G6PD enzyme deficiency among ≤5 years old children attending Al Batool Obstetrics and Pediatric Teaching Hospital in Baqubah city, Diyala, Iraq, and to see whether screening for G6PD enzyme deficiency is worthy.
💡
Sonuç & Katkı:Conclusion: The prevalence of G6PD enzyme deficiency is low, so screening for the enzyme deficiency is not warranted at least in Diyala province.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Screening · G6PD · children

Abstract

Background: G6PD deficiency is the most common gene mutation in the world and the numerous mutations have been classified by the WHO. Objective: is to estimate the prevalence of G6PD enzyme deficiency among ≤5 years old children attending Al Batool Obstetrics and Pediatric Teaching Hospital in Baqubah city, Diyala, Iraq, and to see whether screening for G6PD enzyme deficiency is worthy. Study setting, design and sample size: A hospital based observational cross-sectional study consisting of 1500 children (820 boys and 680 girls), in children aged 5 years and below who attended Al Batool Obstetrics and Pediatric Teaching Hospital in Baqubah city, Diyala, Iraq during period from December 1st 2018 to June30th 2019. Blood samples were collected from each child and analyzed for Hemoglobin (Hb) level, and G6PD enzyme activity assay. Results: Out of 1500 children tested for enzyme activity only 20 children (1.33%) had low enzyme activity. Conclusion: The prevalence of G6PD enzyme deficiency is low, so screening for the enzyme deficiency is not warranted at least in Diyala province.

Anahtar kelimeler
🔖

Bu Makaleye Atıf Yap

AL-EZZİ, J. İ. (2019). Screening for G6PD Enzyme Deficiency Among Children aged Five Years and Below in Diyala Province / Iraq.. Pediatric Practice and Research, Cilt: 7 - Sayı: 2, 9–14. https://ajindex.com/articles/795541

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Minucci A, Giardina B, Zuppi C, Capoluongo E. Glucose-6-phosphate laboratory assay: How, when, and why? IUBMB Life. 2009; 61:27–34. [2] Saha N, Hawkins BR, Wong HB: Distribution of ABO and Rhesus blood groups in G6PD deficient Chinese and Malay newborns; Acta Genet Med Gemellol (Roma). 1975;24(1-2):131-5 [3]Bancone, G.; Kalnoky, M.; Chu, C.S.; Chowwiwat, N.; Kahn, M.; Malleret, B.; el al; The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects. Sci. Rep. 2017, 7, 9822 [4] Getasew Shitaye, Endalamaw Gadisa, Lynn Grignard, Girma Shumie, Wakweya Chali, Temesgen Menberu et al: Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches, Malaria Journal201817:281; doi.org/10.1186/s12936-018-2437-8 [5]Kalnoky, M.; Bancone, G.; Kahn, M.; Chu, C.S.; Chowwiwat, N.;Wilaisrisak, P. et al. Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression. Eur. J. Haematol. 2018, 100, 294–303. [6] Nantakomol, D.; Paul, R.; Palasuwan, A.; Day, N.P.; White, N.J.; Imwong, M. Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency. Malar. J. 2013, 12, 289. [7]Peters, A.L.; Veldthuis, M.; van Leeuwen, K.; Bossuyt, P.M.M.; Vlaar, A.P.J.; van Bruggen, R.; et al: Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females. J. Histochem. Cytochem. Off. J. Histochem. Soc. 2017, 65, 627–636. [8] Ogunlesi, T. A., Dedeke, I. O., Adekanmbi, A. F., Fetuga, M. B. & Ogunfowora, O. B. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Journal of the National Association of Resident Doctors of Nigeria 16, 354–359 (2007). [9] Cunningham, A. D., Hwang, S. & Mochly-Rosen, D. Glucose-6- Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus. Clinics in perinatology 43, 341–354, https://doi.org/10.1016/j.clp.2016.01.010 (2016). [10] WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull. World Health Organ. 1989, 67, 601–611. [11]Amin-Zaki L, Taj El-Din S, Kubba K. Glucose-6-phosphate dehydrogenase deficiency among ethnic groups in Iraq. Bull World Health Organ 1972; 47(1):1-5. [12]Usanga EA, Ameen R. Glucose-6-phosphate dehydrogenase de